share_log

Enveric Biosciences Announces Pharmacology and Safety Data For EB-003, Says 'In Vitro Pharmacology Studies Confirmed EB-003's Ability to Target Desired Serotonergic Receptors'

Enveric Biosciences Announces Pharmacology and Safety Data For EB-003, Says 'In Vitro Pharmacology Studies Confirmed EB-003's Ability to Target Desired Serotonergic Receptors'

Enveric Biosciences宣佈Eb-003的藥理學和安全數據,表示'體外藥理學研究證實Eb-003具有針對所需5-羥色胺受體的能力'
Benzinga ·  10/15 20:06

Enveric Biosciences Announces Pharmacology and Safety Data For EB-003, Says 'In Vitro Pharmacology Studies Confirmed EB-003's Ability to Target Desired Serotonergic Receptors'

Enveric Biosciences宣佈Eb-003的藥理學和安全數據,表示'體外藥理學研究證實Eb-003具有針對所需5-羥色胺受體的能力'

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論